{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:55:16Z","timestamp":1793224516436,"version":"4.5.0"},"reference-count":111,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12891-016-1038-3","type":"journal-article","created":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T02:58:43Z","timestamp":1461639523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":137,"title":["The challenging interplay between rheumatoid arthritis, ageing and comorbidities"],"prefix":"10.1186","volume":"17","author":[{"given":"Marloes","family":"van Onna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Boonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"1038_CR1","unstructured":"Project Europe 2030. http:\/\/espas.eu\/orbis\/sites\/default\/files\/generated\/document\/en\/Project%20Europe%202030.pdf . Accessed 30 December 2015."},{"key":"1038_CR2","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","volume":"73","author":"M Cross","year":"2014","unstructured":"Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, et al. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1316\u201322.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.berh.2011.10.001","volume":"25","author":"B Fautrel","year":"2011","unstructured":"Fautrel B, Verstappen SM, Boonen A. Economic consequences and potential benefits. Best Pract Res Clin Rheumatol. 2011;25:607\u201324.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1038_CR4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11926-014-0468-x","volume":"16","author":"S Gavan","year":"2014","unstructured":"Gavan S, Harrison M, Iglesias C, Barton A, Manca A, Payne K. Economics of stratified medicine in rheumatoid arthritis. Curr Rheumatol Rep. 2014;16:468.","journal-title":"Curr Rheumatol Rep"},{"key":"1038_CR5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.berh.2011.10.009","volume":"25","author":"NJ Gullick","year":"2011","unstructured":"Gullick NJ, Scott DL. Co-morbidities in established rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2011;25:469\u201383.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1038_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","volume":"73","author":"M Dougados","year":"2014","unstructured":"Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2014;73:62\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1038_CR7","doi-asserted-by":"crossref","first-page":"iii30","DOI":"10.1136\/ard.2008.098038","volume":"67","author":"SE Gabriel","year":"2008","unstructured":"Gabriel SE. Why do people with rheumatoid arthritis still die prematurely? Ann Rheum Dis. 2008;67(3):iii30\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"S Gabriel","year":"2009","unstructured":"Gabriel S, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and co-morbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11:229.","journal-title":"Arthritis Res Ther"},{"key":"1038_CR9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.berh.2007.06.002","volume":"21","author":"K Michaud","year":"2007","unstructured":"Michaud K, Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2007;21:885\u2013906.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1038_CR10","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1136\/annrheumdis-2013-204733","volume":"74","author":"M Dougados","year":"2015","unstructured":"Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann Rheum Dis. 2015;74:1725\u201333.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR11","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.284.8.984","volume":"284","author":"CH MacLean","year":"2000","unstructured":"MacLean CH, Louie R, Leake B, McCaffrey DF, Paulus HE, Brook RH, et al. Quality of care for patients with rheumatoid arthritis. JAMA. 2000;284:984\u201392.","journal-title":"JAMA"},{"key":"1038_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/ar974","volume":"5","author":"JJ Goronzy","year":"2003","unstructured":"Goronzy JJ, Weyand CM. Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther. 2003;5:225\u201334.","journal-title":"Arthritis Res Ther"},{"key":"1038_CR13","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrrheum.2013.92","volume":"9","author":"AM Boots","year":"2013","unstructured":"Boots AM, Maier AB, Stinissen P, Masson P, Lories RJ, De Keyser F. The influence of ageing on the development and management of rheumatoid arthritis. Nat Rev Rheumatol. 2013;9:604\u201313.","journal-title":"Nat Rev Rheumatol"},{"key":"1038_CR14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/ni.2588","volume":"14","author":"JJ Goronzy","year":"2013","unstructured":"Goronzy JJ, Weyand CM. Understanding immunosenescence to improve responses to vaccines. Nat Immunol. 2013;14:428\u201336.","journal-title":"Nat Immunol"},{"key":"1038_CR15","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.immuni.2006.05.001","volume":"24","author":"NP Weng","year":"2006","unstructured":"Weng NP. Aging of the immune system: how much can the adaptive immune system adapt? Immunity. 2006;24:495\u20139.","journal-title":"Immunity"},{"key":"1038_CR16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3389\/fimmu.2013.00131","volume":"4","author":"JJ Goronzy","year":"2013","unstructured":"Goronzy JJ, Li G, Yang Z, Weyand CM. The janus head of T cell aging - autoimmunity and immunodeficiency. Front Immunol. 2013;4:131.","journal-title":"Front Immunol"},{"key":"1038_CR17","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1002\/art.11290","volume":"48","author":"RH Straub","year":"2003","unstructured":"Straub RH, Sch\u00f6lmerich J, Cutolo M. The multiple facets of premature aging in rheumatoid arthritis. Arthritis Rheum. 2003;48:2713\u201321.","journal-title":"Arthritis Rheum"},{"key":"1038_CR18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","volume":"14","author":"M Michaud","year":"2013","unstructured":"Michaud M, Balardy L, Moulis G, Gaudin C, Peyrot C, Vellas B, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14:877\u201382.","journal-title":"J Am Med Dir Assoc"},{"key":"1038_CR19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1161\/01.CIR.0000054612.26458.B2","volume":"107","author":"DH Solomon","year":"2003","unstructured":"Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303\u20137.","journal-title":"Circulation"},{"key":"1038_CR20","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","volume":"71","author":"JA Avina-Zubieta","year":"2012","unstructured":"Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D. Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012;71:1524\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR21","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1093\/rheumatology\/kep252","volume":"48","author":"C Meune","year":"2009","unstructured":"Meune C, Touz\u00e9 E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford). 2009;48:1309\u201313.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117952","volume":"10","author":"LR Baghdadi","year":"2015","unstructured":"Baghdadi LR, Woodman RJ, Shanahan EM, Mangoni AA. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis. PLoS One. 2015;10, e0117952.","journal-title":"PLoS One"},{"key":"1038_CR23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ejim.2012.06.016","volume":"23","author":"H John","year":"2012","unstructured":"John H, Kitas G. Inflammatory arthritis as a novel risk factor for cardiovascular disease. Eur J Intern Med. 2012;23:575\u20139.","journal-title":"Eur J Intern Med"},{"key":"1038_CR24","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrrheum.2015.112","volume":"11","author":"MT Nurmohamed","year":"2015","unstructured":"Nurmohamed MT, Heslinga M, Kitas GD. Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol. 2015;11:693\u2013704.","journal-title":"Nat Rev Rheumatol"},{"key":"1038_CR25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/annrheumdis-2014-206624","volume":"74","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74:480\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/ard.2010.143396","volume":"70","author":"J Lindhardsen","year":"2011","unstructured":"Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Torp-Pedersen C, et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann Rheum Dis. 2011;70:929\u201334.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0034-1371542","volume":"35","author":"F Lake","year":"2014","unstructured":"Lake F, Proudman S. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach. Semin Respir Crit Care Med. 2014;35:222\u201338.","journal-title":"Semin Respir Crit Care Med"},{"key":"1038_CR28","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.27405","volume":"62","author":"T Bongartz","year":"2010","unstructured":"Bongartz T, Nannini C, Medina-Velasquez YF, Achenbach SJ, Crowson CS, Ryu JH, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2010;62:1583\u201391.","journal-title":"Arthritis Rheum"},{"key":"1038_CR29","doi-asserted-by":"publisher","unstructured":"Ungprasert P, Srivali N, Cheungpasitporn W, Davis Iii JM. Risk of incident chronic obstructive pulmonary disease in patients with rheumatoid arthritis: A systematic review and meta-analysis. Joint Bone Spine. 2015. doi: 10.1016\/j.jbspin.2015.05.016 . [Epub ahead of print].","DOI":"10.1016\/j.jbspin.2015.05.016"},{"key":"1038_CR30","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar2404","volume":"10","author":"AL Smitten","year":"2008","unstructured":"Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther. 2008;10:R45.","journal-title":"Arthritis Res Ther"},{"key":"1038_CR31","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","volume":"54","author":"E Baecklund","year":"2006","unstructured":"Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006;54:692\u2013701.","journal-title":"Arthritis Rheum"},{"key":"1038_CR32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/rheumatology\/kes189","volume":"52","author":"C Turesson","year":"2013","unstructured":"Turesson C, Matteson EL. Malignancy as a comorbidity in rheumatic diseases. Rheumatology (Oxford). 2013;52:5\u201314.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s10552-009-9298-y","volume":"20","author":"A Parikh-Patel","year":"2009","unstructured":"Parikh-Patel A, White RH, Allen M, Cress R. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control. 2009;20:1001\u201310.","journal-title":"Cancer Causes Control"},{"key":"1038_CR34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/annrheumdis-2013-204575","volume":"73","author":"S Ramiro","year":"2014","unstructured":"Ramiro S, Gaujoux-Viala C, Nam JL, Smolen JS, Buch M, Gossec L, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2014;73:529\u201335.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR35","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0140-6736(10)62349-5","volume":"377","author":"TD Rachner","year":"2011","unstructured":"Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. 2011;377:1276\u201387.","journal-title":"Lancet"},{"key":"1038_CR36","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1002\/art.22117","volume":"54","author":"TP Staa Van","year":"2006","unstructured":"Van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:3104\u201312.","journal-title":"Arthritis Rheum"},{"key":"1038_CR37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3899\/jrheum.101036","volume":"38","author":"R Rajbhandary","year":"2011","unstructured":"Rajbhandary R, Khezri A, Panush RS. Rheumatoid cachexia: what is it and why is it important? J Rheumatol. 2011;38:406\u20138.","journal-title":"J Rheumatol"},{"key":"1038_CR38","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","volume":"29","author":"M Muscaritoli","year":"2010","unstructured":"Muscaritoli M, Anker SD, Argil\u00e9s J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \"cachexia-anorexia in chronic wasting diseases\" and \"nutrition in geriatrics\". Clin Nutr. 2010;29:154\u20139.","journal-title":"Clin Nutr"},{"key":"1038_CR39","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.3899\/jrheum.141629","volume":"42","author":"A Maghraoui El","year":"2015","unstructured":"El Maghraoui A, Sadni S, Rezqi A, Bezza A, Achemlal L, Mounach A. Does Rheumatoid Cachexia Predispose Patients with Rheumatoid Arthritis to Osteoporosis and Vertebral Fractures? J Rheumatol. 2015;42:1556\u201362.","journal-title":"J Rheumatol"},{"key":"1038_CR40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrrheum.2010.105","volume":"6","author":"GD Summers","year":"2010","unstructured":"Summers GD, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD. Rheumatoid cachexia and cardiovascular disease. Nat Rev Rheumatol. 2010;6:445\u201351.","journal-title":"Nat Rev Rheumatol"},{"key":"1038_CR41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00198-012-2057-z","volume":"24","author":"S Verschueren","year":"2013","unstructured":"Verschueren S, Gielen E, O'Neill TW, Pye SR, Adams JE, Ward KA, et al. Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int. 2013;24:87\u201398.","journal-title":"Osteoporos Int"},{"key":"1038_CR42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00198-015-3241-8","volume":"27","author":"H He","year":"2016","unstructured":"He H, Liu Y, Tian Q, Papasian CJ, Hu T, Deng HW. Relationship of sarcopenia and body composition with osteoporosis. Osteoporos Int. 2016;27:473\u201382.","journal-title":"Osteoporos Int"},{"key":"1038_CR43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1358\/mf.2004.26.5.831324","volume":"26","author":"S Appenzeller","year":"2004","unstructured":"Appenzeller S, Bertolo MB, Costallat LT. Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol. 2004;26:339\u201343.","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"1038_CR44","first-page":"491","volume":"20","author":"M Bartolini","year":"2002","unstructured":"Bartolini M, Candela M, Brugni M, Catena L, Mari F, Pomponio G, et al. Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol. 2002;20:491\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"1038_CR45","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.33469","volume":"64","author":"SY Shin","year":"2012","unstructured":"Shin SY, Katz P, Wallhagen M, Julian L. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012;64:1144\u201350.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1038_CR46","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3899\/jrheum.120871","volume":"40","author":"SY Shin","year":"2013","unstructured":"Shin SY, Julian L, Katz P. The relationship between cognitive function and physical function in rheumatoid arthritis. J Rheumatol. 2013;40:236\u201343.","journal-title":"J Rheumatol"},{"key":"1038_CR47","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JAD-2012-111736","volume":"31","author":"K Wallin","year":"2012","unstructured":"Wallin K, Solomon A, K\u00e5reholt I, Tuomilehto J, Soininen H, Kivipelto M. Midlife rheumatoid arthritis increases the risk of cognitive impairment two decades later: a population-based study. J Alzheimers Dis. 2012;31:669\u201376.","journal-title":"J Alzheimers Dis"},{"key":"1038_CR48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0304-3959(01)00457-2","volume":"96","author":"SC Brown","year":"2002","unstructured":"Brown SC, Glass JM, Park DC. The relationship of pain and depression to cognitive function in rheumatoid arthritis patients. Pain. 2002;96:279\u201384.","journal-title":"Pain"},{"key":"1038_CR49","doi-asserted-by":"publisher","unstructured":"Joaquim AF, Appenzeller S. Neuropsychiatric manifestations in rheumatoid arthritis. Autoimmun Rev 2015. doi: 10.1016\/j.autrev.2015.07.015 .","DOI":"10.1016\/j.autrev.2015.07.015"},{"key":"1038_CR50","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1001\/jama.289.23.3095","volume":"289","author":"RC Kessler","year":"2003","unstructured":"Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095\u2013105.","journal-title":"JAMA"},{"key":"1038_CR51","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","volume":"62","author":"RC Kessler","year":"2005","unstructured":"Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617\u201327.","journal-title":"Arch Gen Psychiatry"},{"key":"1038_CR52","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","volume":"52","author":"F Matcham","year":"2013","unstructured":"Matcham F, Rayner L, Steer S, Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford). 2013;52:2136\u201348.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-244X-12-6","volume":"12","author":"T Covic","year":"2012","unstructured":"Covic T, Cumming SR, Pallant JF, Manolios N, Emery P, Conaghan PG, Tennant A. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry. 2012;12:6. doi: 10.1186\/1471-244X-12-6 .","journal-title":"BMC Psychiatry"},{"key":"1038_CR54","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1176\/appi.psy.51.4.338","volume":"51","author":"EY Lok","year":"2010","unstructured":"Lok EY, Mok CC, Cheng CW, Cheung EF. Prevalence and determinants of psychiatric disorders in patients with rheumatoid arthritis. Psychosomatics. 2010;51:338\u2013338.e8.","journal-title":"Psychosomatics"},{"key":"1038_CR55","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1136\/ard.49.11.916","volume":"49","author":"DMFM Heijde Van der","year":"1990","unstructured":"Van der Heijde DMFM, van 't Hof MA, van Riel PLCM, Theunisse LAM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disase activity score. Ann Rheum Dis. 1990;49:916\u201320.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/art.1780230202","volume":"23","author":"JF Fries","year":"1980","unstructured":"Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137\u201345.","journal-title":"Arthritis Rheum"},{"key":"1038_CR57","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1002\/art.1780241012","volume":"24","author":"RS Pinals","year":"1981","unstructured":"Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum. 1981;24:1308\u201315.","journal-title":"Arthritis Rheum"},{"key":"1038_CR58","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/rheumatology\/ket224","volume":"52","author":"VK Ranganath","year":"2013","unstructured":"Ranganath VK, Maranian P, Elashoff DA, Woodworth T, Khanna D, Hahn T, et al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology (Oxford). 2013;52:1809\u201317.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1038_CR59","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/rheumatology\/ket449","volume":"53","author":"MB Arnold","year":"2014","unstructured":"Arnold MB, Bykerk VP, Boire G, Haraoui BP, Hitchon C, Thorne C, CATCH Investigators, et al. Are there differences between young- and older-onset early inflammatory arthritis and do these impact outcomes? An analysis from the CATCH cohort. Rheumatology (Oxford). 2014;53(6):1075\u201386.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR60","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1002\/art.22193","volume":"54","author":"A Zink","year":"2006","unstructured":"Zink A, Strangfeld A, Schneider M, Herzer P, Hierse F, Stoyanova-Scholz M, et al. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials. Arthritis Rheum. 2006;54:3399\u2013407.","journal-title":"Arthritis Rheum"},{"key":"1038_CR61","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/art.23247","volume":"59","author":"GR Burmester","year":"2008","unstructured":"Burmester GR, Ferraccioli G, Flipo RM, Monteagudo-S\u00e1ez I, Unnebrink K, Kary S, et al. Clinical remission and\/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study. Arthritis Rheum. 2008;59:32\u201341.","journal-title":"Arthritis Rheum"},{"key":"1038_CR62","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1002\/art.23794","volume":"58","author":"T Sokka","year":"2008","unstructured":"Sokka T, Hetland ML, M\u00e4kinen H, Kautiainen H, H\u00f8rslev-Petersen K, Luukkainen RK, et al. Questionnaires in Standard Monitoring of Patients With Rheumatoid Arthritis Group. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum. 2008;58:2642\u201351.","journal-title":"Arthritis Rheum"},{"key":"1038_CR63","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1136\/ard.2005.037903","volume":"64","author":"E Krishnan","year":"2005","unstructured":"Krishnan E, H\u00e4kkinen A, Sokka T, Hannonen P. Impact of age and comorbidities on the criteria for remission and response in rheumatoid arthritis. Ann Rheum Dis. 2005;64:1350\u20132.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR64","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/rheumatology\/kem051","volume":"46","author":"T Sokka","year":"2007","unstructured":"Sokka T, M\u00e4kinen H, Hannonen P, Pincus T. Most people over age 50 in the general population do not meet ACR remission criteria or OMERACT minimal disease activity criteria for rheumatoid arthritis. Rheumatology (Oxford). 2007;46:1020\u20133.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR65","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3899\/jrheum.090805","volume":"37","author":"J Toms","year":"2010","unstructured":"Toms J, Soukup T, Bradna P, Hrncir Z. Disease activity composite indices in patients with rheumatoid arthritis and concomitant fibromyalgia. J Rheumatol. 2010;37:468.","journal-title":"J Rheumatol"},{"key":"1038_CR66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/rheumatology\/keq334","volume":"50","author":"H Radner","year":"2011","unstructured":"Radner H, Smolen JS, Aletaha D. Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology (Oxford). 2011;50:381\u20138.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR67","doi-asserted-by":"publisher","unstructured":"Stoffer MA, Schoels MM, Smolen JS, et al. Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis. 2015:doi: 10.1136\/annrheumdis-2015-207526 . [Epub ahead of print].","DOI":"10.1136\/annrheumdis-2015-207526"},{"key":"1038_CR68","first-page":"2366","volume":"31","author":"HM Kremers","year":"2004","unstructured":"Kremers HM, Nicola P, Crowson CS, O'Fallon WM, Gabriel SE. Therapeutic strategies in rheumatoid arthritis over a 40-year period. J Rheumatol. 2004;31:2366\u201373.","journal-title":"J Rheumatol"},{"key":"1038_CR69","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/kel144","volume":"45","author":"L Fraenkel","year":"2006","unstructured":"Fraenkel L, Rabidou N, Dhar R. Are rheumatologists' treatment decisions influenced by patients' age? Rheumatology (Oxford). 2006;45:1555\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR70","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/ard.2005.051144","volume":"65","author":"Z Tutuncu","year":"2006","unstructured":"Tutuncu Z, Reed G, Kremer J, Kavanaugh A. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann Rheum Dis. 2006;65:1226\u20139.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR71","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.3899\/jrheum.141112","volume":"42","author":"C Roubille","year":"2015","unstructured":"Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative. J Rheumatol. 2015;42:1767\u201380.","journal-title":"J Rheumatol"},{"key":"1038_CR72","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1001\/archinte.167.22.2453","volume":"167","author":"MF Leitzmann","year":"2007","unstructured":"Leitzmann MF, Park Y, Blair A, Ballard-Barbash R, Mouw T, Hollenbeck AR, Schatzkin A. Physical activity recommendations and decreased risk of mortality. Arch Intern Med. 2007;167:2453\u201360.","journal-title":"Arch Intern Med"},{"key":"1038_CR73","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","volume":"363","author":"A Berrington de Gonzalez","year":"2010","unstructured":"Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211\u20139.","journal-title":"N Engl J Med"},{"key":"1038_CR74","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.2008.096487","volume":"69","author":"D Sugiyama","year":"2010","unstructured":"Sugiyama D, Nishimura K, Tamaki K, Tsuji G, Nakazawa T, Morinobu A, Kumagai S. Impact of smoking as a risk factor for developing rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2010;69:70\u201381.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR75","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2009.120899","volume":"70","author":"H K\u00e4llberg","year":"2011","unstructured":"K\u00e4llberg H, Ding B, Padyukov L, Bengtsson C, R\u00f6nnelid J, Klareskog L, et al. EIRA Study Group. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70:508\u201311.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1038_CR76","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/art.10174","volume":"46","author":"DL Mattey","year":"2002","unstructured":"Mattey DL, Hutchinson D, Dawes PT, Nixon NB, Clarke S, Fisher J, et al. Smoking and disease severity in rheumatoid arthritis: association with polymorphism at the glutathione S-transferase M1 locus. Arthritis Rheum. 2002;46(3):640\u20136.","journal-title":"Arthritis Rheum"},{"key":"1038_CR77","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/ard.2006.065060","volume":"66","author":"A Finckh","year":"2007","unstructured":"Finckh A, Dehler S, Costenbader KH, Gabay C, Swiss Clinical Quality Management project for RA. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2007;66:1066\u201371.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR78","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1136\/annrheumdis-2013-203940","volume":"73","author":"DP Rooy De","year":"2014","unstructured":"De Rooy DP, van Nies JA, Kapetanovic MC, Kristjansdottir H, Andersson ML, Forslind K, et al. Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts. Ann Rheum Dis. 2014;73:1384\u20137.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/kem260","volume":"47","author":"GS Metsios","year":"2008","unstructured":"Metsios GS, Stavropoulos-Kalinoglou A, Veldhuijzen van Zanten JJ, Treharne GJ, Panoulas VF, et al. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford). 2008;47:239\u201348.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR80","doi-asserted-by":"crossref","unstructured":"Hurkmans E, van der Giesen FJ, Vliet Vlieland TP, Schoones J, Van den Ende EC. Dynamic exercise programs (aerobic capacity and\/or muscle strength training) in patients with rheumatoid arthritis. Cochrane Database Syst Rev. 2009;CD006853.","DOI":"10.1002\/14651858.CD006853.pub2"},{"key":"1038_CR81","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.physbeh.2007.12.012","volume":"94","author":"G Plasqui","year":"2008","unstructured":"Plasqui G. The role of physical activity in rheumatoid arthritis. Physiol Behav. 2008;94:270\u20135.","journal-title":"Physiol Behav"},{"key":"1038_CR82","doi-asserted-by":"crossref","first-page":"681640","DOI":"10.4061\/2011\/681640","volume":"2011","author":"JK Cooney","year":"2011","unstructured":"Cooney JK, Law RJ, Matschke V, Lemmey AB, Moore JP, Ahmad Y, et al. Benefits of exercise in rheumatoid arthritis. J Aging Res. 2011;2011:681640.","journal-title":"J Aging Res"},{"key":"1038_CR83","doi-asserted-by":"crossref","unstructured":"Veldhuijzen van Zanten JJ, Rouse PC, Hale ED, Ntoumanis N, Metsios GS, Duda JL, et al. Perceived Barriers, Facilitators and Benefits for Regular Physical Activity and Exercise in Patients with Rheumatoid Arthritis: A Review of the Literature. Sports Med 2015 Jul 29. [Epub ahead of print]","DOI":"10.1007\/s40279-015-0363-2"},{"key":"1038_CR84","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/acr.21710","volume":"65","author":"S Ajeganova","year":"2013","unstructured":"Ajeganova S, Andersson ML, Hafstr\u00f6m I, BARFOT Study Group. Association of obesity with worse disease severity in rheumatoid arthritis as well as with comorbidities: a long-term followup from disease onset. Arthritis Care Res (Hoboken). 2013;65:78\u201387.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1038_CR85","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/ard.2006.053488","volume":"66","author":"JA Papadakis","year":"2007","unstructured":"Papadakis JA, Sidiropoulos PI, Karvounaris SA, Vrentzos GE, Spanakis EK, Ganotakis ES, Kritikos HD, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007;66:28\u201333.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR86","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/ard.2007.078832","volume":"67","author":"AH Mil Van der Helm-van","year":"2008","unstructured":"Van der Helm-van Mil AH, van der Kooij SM, Allaart CF, Toes RE, Huizinga TW. A high body mass index has a protective effect on the amount of joint destruction in small joints in early rheumatoid arthritis. Ann Rheum Dis. 2008;67:769\u201374.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR87","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","volume":"69","author":"MJ Peters","year":"2010","unstructured":"Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325\u201331.","journal-title":"Ann Rheum Dis"},{"key":"1038_CR88","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","volume":"67","author":"N Ronda","year":"2015","unstructured":"Ronda N, Greco D, Adorni MP, Zimetti F, Favari E, Hjeltnes G, et al. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheumatol. 2015;67:1155\u201364.","journal-title":"Arthritis Rheumatol"},{"key":"1038_CR89","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2174\/13894501113149990176","volume":"14","author":"R Sakthiswary","year":"2013","unstructured":"Sakthiswary R, Das S. The effects of TNF \u03b1 antagonist therapy on bone metabolism in rheumatoid arthritis: a systematic review. Curr Drug Targets. 2013;14:1552\u20137.","journal-title":"Curr Drug Targets"},{"key":"1038_CR90","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-012-2073-z","volume":"24","author":"MC Goes Van der","year":"2013","unstructured":"Van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, et al. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied? Osteoporos Int. 2013;24:1429\u201336.","journal-title":"Osteoporos Int."},{"key":"1038_CR91","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.2015.1007041","volume":"14","author":"\u00c9 Toussirot","year":"2015","unstructured":"Toussirot \u00c9. Effects of TNF\u03b1 inhibitors on adiposity and other cardiovascular risk factors: implications for the cardiovascular prognosis in patients with rheumatoid arthritis. Expert Opin Drug Saf. 2015;14:525\u201332.","journal-title":"Expert Opin Drug Saf"},{"key":"1038_CR92","doi-asserted-by":"crossref","first-page":"R197","DOI":"10.1186\/ar3169","volume":"12","author":"IL Engvall","year":"2010","unstructured":"Engvall IL, Tengstrand B, Brismar K, Hafstr\u00f6m I. Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months. Arthritis Res Ther. 2010;12:R197.","journal-title":"Arthritis Res Ther"},{"key":"1038_CR93","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1093\/rheumatology\/kem291","volume":"46","author":"GS Metsios","year":"2007","unstructured":"Metsios GS, Stavropoulos-Kalinoglou A, Douglas KM, Koutedakis Y, Nevill AM, Panoulas VF, et al. Blockade of tumour necrosis factor-alpha in rheumatoid arthritis: effects on components of rheumatoid cachexia. Rheumatology (Oxford). 2007;46:1824\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR94","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/ajcn\/84.6.1463","volume":"84","author":"SM Marcora","year":"2006","unstructured":"Marcora SM, Chester KR, Mittal G, Lemmey AB, Maddison PJ. Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr. 2006;84:1463\u201372.","journal-title":"Am J Clin Nutr"},{"key":"1038_CR95","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s10067-008-0855-7","volume":"27","author":"J Serelis","year":"2008","unstructured":"Serelis J, Kontogianni MD, Katsiougiannis S, Bletsa M, Tektonidou MG, Skopouli FN. Effect of anti-TNF treatment on body composition and serum adiponectin levels of women with rheumatoid arthritis. Clin Rheumatol. 2008;27:795\u20137.","journal-title":"Clin Rheumatol"},{"key":"1038_CR96","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpsychores.2015.04.008","volume":"79","author":"R Abbott","year":"2015","unstructured":"Abbott R, Whear R, Nikolaou V, Bethel A, Coon JT, Stein K, et al. Tumour necrosis factor-\u03b1 inhibitor therapy in chronic physical illness: A systematic review and meta-analysis of the effect on depression and anxiety. J Psychosom Res. 2015;79:175\u201384.","journal-title":"J Psychosom Res"},{"key":"1038_CR97","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/rheumatology\/keq327","volume":"50","author":"J Kekow","year":"2011","unstructured":"Kekow J, Moots R, Khandker R, Melin J, Freundlich B, Singh A. Improvements in patient-reported outcomes, symptoms of depression and anxiety, and their association with clinical remission among patients with moderate-to-severe active early rheumatoid arthritis. Rheumatology (Oxford). 2011;50:401\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1038_CR98","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","volume":"363","author":"DW McCarey","year":"2004","unstructured":"McCarey DW, McInnes IB, Madhok R, Hampson R, Scherbakov O, Ford I, et al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet. 2004;363:2015\u201321.","journal-title":"Lancet"},{"key":"1038_CR99","doi-asserted-by":"publisher","unstructured":"Schoenfeld SR, Lu L, Rai SK, Seeger JD, Zhang Y, Choi HK. Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 2015. doi: 10.1136\/annrheumdis-2015-207714 .","DOI":"10.1136\/annrheumdis-2015-207714"},{"key":"1038_CR100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00198-010-1326-y","volume":"22","author":"S Ferrari-Lacraz","year":"2011","unstructured":"Ferrari-Lacraz S, Ferrari S. Do RANKL inhibitors (denosumab) affect inflammation and immunity? Osteoporos Int. 2011;22:435\u201346.","journal-title":"Osteoporos Int"},{"key":"1038_CR101","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/art.23417","volume":"58","author":"SB Cohen","year":"2008","unstructured":"Cohen SB, Dore RK, Lane NE, et al. Denosumab Rheumatoid Arthritis Study Group. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum. 2008;58:1299\u2013309.","journal-title":"Arthritis Rheum"},{"key":"1038_CR102","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/art.27304","volume":"62","author":"S Sacre","year":"2010","unstructured":"Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum. 2010;62:683\u201393.","journal-title":"Arthritis Rheum"},{"issue":"635","key":"1038_CR103","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.3399\/bjgp15X685297","volume":"65","author":"FL Bawa","year":"2015","unstructured":"Bawa FL, Mercer SW, Atherton RJ, Clague F, Keen A, Scott NW, et al. Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis. Br J Gen Pract. 2015;65(635):e387\u2013400.","journal-title":"Br J Gen Pract"},{"key":"1038_CR104","doi-asserted-by":"crossref","unstructured":"Richards BL, Whittle SL, Buchbinder R. Antidepressants for pain management in rheumatoid arthritis. Cochrane Database Syst Rev. 2011:CD008920.","DOI":"10.1002\/14651858.CD008920.pub2"},{"key":"1038_CR105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3899\/jrheum.120338","volume":"90","author":"BL Richards","year":"2012","unstructured":"Richards BL, Whittle SL, van der Heijde DM, Buchbinder R. The efficacy and safety of antidepressants in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl. 2012;90:21\u20137.","journal-title":"J Rheumatol Suppl"},{"key":"1038_CR106","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37\u201343.","journal-title":"Lancet"},{"key":"1038_CR107","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00296-014-3196-7","volume":"35","author":"E Loza","year":"2015","unstructured":"Loza E, Lajas C, Andreu JL, Balsa A, Gonz\u00e1lez-\u00c1lvaro I, Illera O, et al. Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int. 2015;35:445\u201358.","journal-title":"Rheumatol Int"},{"key":"1038_CR108","doi-asserted-by":"crossref","first-page":"e33559","DOI":"10.1371\/journal.pone.0033559","volume":"7","author":"C Konrat","year":"2012","unstructured":"Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012;7:e33559.","journal-title":"PLoS One"},{"key":"1038_CR109","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0895-4356(02)00585-1","volume":"56","author":"V Groot De","year":"2003","unstructured":"De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56:221\u20139.","journal-title":"J Clin Epidemiol"},{"key":"1038_CR110","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s10067-015-3101-0","volume":"34","author":"Y Miedany El","year":"2015","unstructured":"El Miedany Y. Co-morbidity index in rheumatoid arthritis: time to think. Clin Rheumatol. 2015;34:1995\u20132000.","journal-title":"Clin Rheumatol"},{"key":"1038_CR111","first-page":"46","volume":"23","author":"J Mold","year":"1991","unstructured":"Mold J, Blake G, Becker L. Goal-oriented medical care. Fam Med. 1991;23:46\u201351.","journal-title":"Fam Med"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-016-1038-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1038-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-016-1038-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T21:45:31Z","timestamp":1748900731000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-016-1038-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":111,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1186\/s12891-016-1038-3","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]},"article-number":"184"}}